Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Atropos Health Publishes Methodology to Expand Precision Evidence Content

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced the preprint of a new study detailing a high-throughput, standardized observational evidence-creation workflow capable of generating evidence at a scale previously unattainable in healthcare.

The publication, “High-Throughput Observational Evidence Generation Using Linked Electronic Health Record and Claims Data,” describes how Atropos Health's proprietary workflow — applied to linked electronic health record (EHR) and administrative claims data produces scalar narrative research-style summaries, each subjected to structured clinical and statistical quality control prior to dissemination.

"Publishing this work is an expression of who we are as a company. We believe that if you are going to generate evidence that influences medical decisions — decisions that affect real patients — you have an obligation to be transparent about your methods, open to scrutiny, and held to the highest standards,” said Dr Saurabh Gombar, Chief Medical Officer and Co-Founder of Atropos Health. “This publication invites the scientific community to examine how we work, challenge our assumptions, and build on our findings. That is exactly how medicine should advance — openly, collaboratively, and with the patient always at the center."

The research addresses a long-standing challenge in observational medicine: the fragmented, outcome-sparse nature of traditional real-world studies, which often differ in design, population definition, and outcome selection — producing inconsistent conclusions that erode confidence among clinicians, payers, and life-science stakeholders.

“By standardizing how clinical questions are posed, broadening what outcomes are reported, and packaging results into comprehensive, multi-stakeholder evidence artifacts, we’re building the next generation of scaled evidence content for Artificial Intelligence (AI) and large language model (LLM) training in healthcare,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “Atropos Health's workflow represents a fundamental shift in how real-world evidence is created and consumed.”

Today’s announcement follows the release of the expanded application of the Atropos Evidence Agent, an expert real-world evidence agent, at Stanford Medicine.

Read the full paper here.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improve individual patient outcomes with data-driven care, and expedite research that advances the field of medicine. We aim to transform healthcare with timely, relevant, real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or X (Twitter).

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.67
+0.97 (0.40%)
AAPL  308.63
+14.25 (4.84%)
AMD  517.82
-23.06 (-4.26%)
BAC  58.73
+0.37 (0.63%)
GOOG  356.18
-1.71 (-0.48%)
META  582.90
-30.01 (-4.90%)
MSFT  390.49
+6.21 (1.62%)
NVDA  194.83
-2.75 (-1.39%)
ORCL  140.27
-2.23 (-1.56%)
TSLA  393.45
-31.85 (-7.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.